One-Year, Open-Label Extension Study on the Safety and Efficacy of Abiraterone Acetate Fine Particle Formulation in Patients With Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Clinical Medicine Insights: Urology, 2020, v. 13, p. 1, doi. 10.1177/1179561120910125
- By:
- Publication type:
- Article